Page 107 - Genentech News Today

Rick found strength in the leukemia community.

News, features, and commentary about cancer-related issues

Atezolizumab - made by Genentech, a Roche company - is an immunotherapy drug that empowers a patients own immune system to seek and destroy cancerous cells. The treatment is currently offered by transfusion to NHS patients with a range of cancers, including lung, breast, liver and bladder.

UK News: Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England said on Tuesday hundreds of eligible patients trea

UK's NHS introduces groundbreaking cancer treatment injection, potentially reducing treatment times for eligible patients by three quarters

Pharma drug research and development is undergoing changes thanks to the power of artificial intelligence

Britains National Health Service will be the first in the world to offer an injection that treats cancer of patients in England which could cut treatment times by up to three quarters (7 minutes).

Hidden HIV cells are responsible for the virus permanently remaining in the body and cannot be treated by current therapy options. In new research, an existing blood cancer drug has shown promise in killing these "silent" HIV cells.

PagerDuty Operations Cloud’s AI-generated runbooks accelerate automation efforts to drive cost optimization and efficiency for customers ...

For patients with Parkinson disease, those whose caregivers have depression symptoms have worse QOL and higher emergency department use.